Clinical Trials Browser

Neoplasm, Residual × Genitourinary × Clear all

NCT07112612 2026-01-12

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Not yet recruiting

Prostatic Neoplasms, Neoplasm, Residual

NCT03441464 2022-02-25

Feasibility of the LUM Imaging System for Detection of Prostate Cancer

Phase 1/2 Terminated

Prostatic Neoplasms, Neoplasm, Residual

NCT02714790 2016-03-23

LAM-MMR

GenitourinaryOther hematologic neoplasm

Wilms Tumor, Leukemia, Myeloid, Acute, Neoplasm, Residual